European Pharmaceutical Review

JULY 21, 2023

A recent report from the US Food and Drug Administration (FDA) shows that while the number of new drug shortages has fallen significantly from a high of 250 in 2011 to 49 in 2022, there was an increase in new drug shortages year-on-year. Additionally, Brexit has introduced uncertainty and disruption, further impacting the sector.

Pharmaceutical 94

Pharmaceutical Food and Drug Administration Transportation Manufacturing 94

European Pharmaceutical Review

JANUARY 9, 2024

Adding these developments with the addition of connected IoT devices, supply chain restructuring and consideration for our code of ethics will give us a glimpse at how pharmaceutical production will look in future. Internet] US Food and Drug Administration (FDA). Tuijin Jishu / Propuls. 2023; 44(3):1384-1392. cited 2023Dec].

Pharmaceutical manufacturing 122

Pharmaceutical manufacturing Manufacturing Pharmaceutical Food and Drug Administration 122

Rep-Lite

NOVEMBER 30, 2023

The Unique Challenges of B2B Medical Sales B2B medical sales come with their own set of challenges, including: Regulatory Compliance: The healthcare industry is highly regulated, and medical sales professionals must navigate complex compliance requirements, such as HIPAA and FDA regulations. This is how you bring value.

B2B Sales 52

B2B Sales Medical sales Consulting Sales 52

Contrarian Sales Techniques

JANUARY 23, 2024

The map leads you through regulatory landscapes, navigating intricate FDA and compliance guidelines. And of course, the art of the sale shines bright, with modules honing your communication skills, presentation techniques, and the delicate dance of ethical marketing. But let's be real. Next, prepare for lift-off.

Pharmaceutical Sales 52

Pharmaceutical Sales Pharmaceutical Sales Ethics 52

Legacy MEDSearch

AUGUST 10, 2023

Acorai has ethics approval in 5 countries, including the U.S., “A massive inflection point in our device development journey” Acorai’s CEO and Co-Founder Filip Peters said, “We could not be more delighted with the decision from the FDA, and it constitutes a huge milestone for us as a company. .

Food and Drug Administration 52

Food and Drug Administration Management Recruitment Medical 52

Rep-Lite

MARCH 14, 2024

There is also the option of participating in professional development courses that enhance skills like communication and compliance with healthcare regulations for ethical conduct. This also requires medical sales representatives to be familiar with clinical data based on research and FDA regulations to ensure compliance.

Medical sales reps 52

Medical sales reps Medical sales Medical Sales 52

pharmaphorum

NOVEMBER 16, 2022

Wykoff about the results from Apellis Pharmaceuticals’ OAKS study on intravitreal pegcetacoplan for geographic atrophy (GA), otherwise known as atrophic or dry age-related macular degeneration (AMD), a leading cause of blindness worldwide. After all, GA is almost impossible to treat.

Safety 100

Safety Patients Consulting Prospecting 100

Nixon Gwilt Law

DECEMBER 16, 2021

Click here to find out how to leverage these new codes in an insightful post by RPM Practice Lead Kaitlyn O’Connor. So much so that we’ve recently welcomed 20-year Food and Drug Law veteran and FDA expert Mark Mansour, Esq., serves as the lead of NGL’s busy RPM Practice. Kaitlyn O’Connor, Esq., Don’t wait!

Healthcare 52

Healthcare Healthcare Food and Drug Administration Ethics 52

World of DTC Marketing

MARCH 17, 2022

But it’s’ still the leading cause of cancer deaths. This leads to an ethical question: Should we deny hope to cancer patients because a drug may not work, or should the FDA only approve cancer drugs that show significant clinical benefits (i.e., American Cancer Society’s ACS ). sustaining life)?

Food and Drug Administration 255

Food and Drug Administration Medical Ethics Patients 255

Nixon Gwilt Law

MAY 17, 2024

There was something for every healthcare innovator to apply to their business—from ways to navigate the latest regulatory developments to successfully selling your product(s) to the nation’s leading health systems. Don’t miss the details — There are important considerations to account for early-on that may impact your timeline and budget.

Healthcare 52

Healthcare Healthcare Patients Training 52

Pharma Marketing Network

JUNE 11, 2020

Yeah, I even wanted to wear the shirt to this FDA meeting. You know, in November 2009, the FDA held a public hearing about the promotion of Food and Drug Administrative Related Regulated Medical Products, using the internet and social media tools. And I was glad I had been dieting a few weeks before that. So, I didn’t look so bad.

Media 52

Media Pharma Ethics Consulting 52

PM360

JUNE 11, 2022

For example, everyone must be steeped in both FDA and FTC guidelines. A Patient-Centric Month Leads to Results. I appreciate companies that are ethical, stable, financially transparent, and who have their potential customers’ best interests at stake. Be clear in your governance documents and training to level set expectations.

Patients 59

Patients Pharma Education Media 59

pharmaphorum

NOVEMBER 3, 2022

Food and Drug Administration’s (FDA) draft guidance, “ Digital Health Technologies for Remote Data Acquisition in Clinical Investigations ”. The increasing knowledge gap will hold us back from advancing the ethical, effective, equitable, and safe use of digital medicine to reimagine healthcare and improve lives.

Pharma 80

Pharma Medicine Education Recruitment 80

Salesforce

JUNE 3, 2021

But incentives like free lottery tickets or vouchers for free tickets to sporting events along with the FDA recently authorizing the Pfizer-BioNTech vaccine for emergency use in those aged 12-15 are propelling the continued effort to vaccinate as many people as possible.

Healthcare 52

Healthcare Healthcare Management Healthcare Provider 52

Cadensee

JULY 20, 2021

So, it's important for moral reasons, for ethical reasons, but it's really, really, really empowered by digital. So, you see on one side, there's a special body of the FDA trying to listen to patients to find new targets for health and for pharmaceutical technology. When do you think it is the most important? So, this is my thinking.

Food and Drug Administration 52

Food and Drug Administration Doctors Healthcare Healthcare 52

World of DTC Marketing

AUGUST 25, 2020

grossly misrepresented data about a therapy,” said Dr. Walid Gellad, who leads the Center for Pharmaceutical Policy and Prescribing at the University of Pittsburgh. That should tell you all you need to know about how bad things are with the FDA and trust in drug approvals. For the first time, I am now in fear of FDA drug approvals.

Food and Drug Administration 188

Food and Drug Administration FDA Ethics Prescription 188